US Executive Officer Management Changes SEC — May 28, 2026

28-05-2026

Braemar Hotels & Resorts Inc. appointed Eric Batis to its Board of Directors on May 21, 2026, to serve until the next annual meeting. Concurrently, directors Stefani Danielle Carter and Rebecca Musser resigned effective the same date, with no disagreements cited. No additional compensation or material transactions were reported for Mr. Batis.

• · Mr. Batis was not appointed to any committee at the time of his appointment.
• · Mr. Batis serves as COO of Ashford Inc., overseeing day-to-day operations.
• · No additional compensation will be paid to Mr. Batis for his board duties.
• · Resignations of Carter and Musser were not due to any disagreement with the company.

28-05-2026

Hanmi Financial Corp (HAFC) held its 2026 Annual Meeting on May 27, 2026, where shareholders voted on four items, including the election of ten directors, an advisory vote on executive compensation, approval of the 2026 Employee Stock Purchase Plan (ESPP), and ratification of Crowe LLP as auditor. All proposals passed with strong support; however, director Gideon Yu resigned from the Board effective May 22, 2026, prior to the meeting, and did not stand for reelection. The resignation was not due to any disagreement with the company.

• · Gideon Yu resigned from the Board of Hanmi Financial Corporation and Hanmi Bank effective May 22, 2026, and did not stand for reelection at the 2026 Annual Meeting.
• · Yu had served on the Board since 2021 and was a member of the Nominating and Corporate Governance Committee and Risk, Compliance and Planning Committees at the time of his resignation.
• · The 2026 Employee Stock Purchase Plan (ESPP) was approved by shareholders with 24,886,127 votes 'For', 12,400 'Against', and 5,448 'Abstain' (excluding broker non-votes).
• · Advisory vote on executive compensation received 24,534,573 'For', 361,059 'Against', and 8,343 'Abstain' (excluding broker non-votes).
• · Ratification of Crowe LLP as auditor for FY 2026 received 26,350,596 'For', 68,179 'Against', and 2,224 'Abstain' (no broker non-votes for this proposal).

28-05-2026

FrontView REIT appointed Timothy G. McHugh, Co-President and CFO of Welltower Inc., to its Board of Directors as an independent director, effective May 28, 2026. McHugh brings extensive public REIT leadership, capital markets, and net-lease investment experience to FrontView as the company continues to scale its differentiated platform. No financial metrics or performance data were disclosed in this filing.

• · McHugh has served as Co-President and CFO of Welltower, the largest REIT in the S&P 500 by market capitalization.
• · He joined Welltower in 2016 and has held roles including Treasurer, SVP of Capital Markets, and EVP and CFO.
• · FrontView's portfolio as of March 31, 2026, consisted of 309 direct frontage properties across 36 states, leased primarily to service and necessity-based tenants across 16 industries.
• · The appointment is effective May 28, 2026.

28-05-2026

iRhythm Holdings, Inc. held its 2026 Annual Meeting on May 27, 2026, with 89.69% of shares represented. Stockholders approved all proposals, including the election of nine directors, the 2026 Equity Incentive Plan (replacing the 2016 plan), an amended certificate of incorporation removing the pass-through voting provision, ratification of KPMG LLP as auditor, and an advisory vote on executive compensation. Notably, director Bruce Bodaken received 7,092,364 votes withheld (the highest among nominees), and the advisory vote on executive compensation had 748,553 abstentions, indicating some shareholder dissent.

• · Bruce Bodaken received 7,092,364 votes withheld, the highest withheld count among all director nominees.
• · The advisory vote on executive compensation had 748,553 abstentions, indicating notable shareholder concerns.
• · Proposal 3 (removing pass-through voting provision) passed with 27,297,969 votes for and only 21,366 against.
• · KPMG LLP was ratified as auditor with 29,446,860 votes for and 16,853 against, with no broker non-votes.
• · The 2026 Equity Incentive Plan replaces the 2016 Equity Incentive Plan and was approved with 26,812,921 votes for.

28-05-2026

Neurocrine Biosciences held its 2026 Annual Meeting on May 27, 2026, where stockholders elected three Class III directors (Kevin C. Gorman, Gary A. Lyons, Johanna Mercier) for terms expiring in 2029, approved the Amended 2025 Equity Incentive Plan, ratified Ernst & Young as independent auditor for FY2026, and approved executive compensation on an advisory basis. All four proposals passed with strong majority support, though director Johanna Mercier received the highest number of votes withheld (10,094,338) among the nominees.

• · The Amended 2025 Plan was approved with 79,131,622 votes for, 5,568,926 against, and 65,732 abstentions.
• · Ratification of Ernst & Young LLP received 83,880,185 votes for, 6,170,483 against, and 67,957 abstentions (no broker non-votes).
• · Advisory vote on executive compensation passed with 78,993,894 for, 5,669,155 against, and 103,231 abstentions.
• · Class I Directors (Rastetter, Morrow, Norwalk, Poon) continue until 2027; Class II Directors (Gano, Pops, Sharp, Sherwin) continue until 2028.
• · The filing date is May 28, 2026, and the event date is May 27, 2026.

28-05-2026

On May 8, 2026, Michael Zapata resigned as CEO and Chairman of Schmitt Industries, Inc., with no disagreement cited. Following his departure, Charles Davidson is the sole remaining director and will fill board vacancies and conduct business per Oregon law.

• · Resignations were effective May 8, 2026.
• · Neither resignation resulted from any disagreement with the company.
• · Charles Davidson is the sole remaining board member.
• · The company's common stock trades under the symbol SMIT with no par value.

28-05-2026

On May 27, 2026, First United Corp appointed Jason B. Rush, age 55, as Chairman of the Board. Mr. Rush, who was elected to the Board at the 2026 annual meeting on May 7, 2026, also serves as the Corporation's President and CEO (appointed effective January 1, 2026). No transactions requiring disclosure under Item 404(a) have occurred since the beginning of fiscal 2024, and none are proposed for the remainder of fiscal 2026.

• · Mr. Rush was elected to the Board by shareholders at the 2026 annual meeting on May 7, 2026.
• · He has been employed by First United since October 1993, starting as a Management Trainee.
• · His prior roles include Senior Vice President & COO (Jan 2017 – Dec 2025), Senior Vice President & Chief Risk Officer and Director of Operations and Support (2006–2017).
• · His compensatory arrangements are incorporated by reference from the definitive proxy statement filed March 26, 2025.
• · No reportable transactions with Mr. Rush or his affiliates occurred since the start of fiscal 2024, and none are proposed for the remainder of fiscal 2026.

28-05-2026

First Business Financial Services, Inc. (FBIZ) announced the appointment of Scott M. Ferris to its Board of Directors, effective June 1, 2026. Mr. Ferris brings extensive experience from BMO Financial Group, where he served as Managing Director leading commercial banking within the Financial Institutions Group until his retirement in January 2025. The appointment is expected to support the company's long-term growth strategy.

• · Scott M. Ferris retired from BMO Financial Group in January 2025 after serving as Managing Director leading commercial banking within the Financial Institutions Group since November 2006.
• · Mr. Ferris joined BMO in 1985 and held various roles in commercial and corporate banking before advancing to senior leadership.
• · He brings expertise in credit, liquidity, market, and operational risk management, as well as experience with banking and market regulators.

28-05-2026

Provident Financial Holdings, Inc. announced the resignation of David S. Weiant as Senior Vice President and Chief Lending Officer of its subsidiary, Provident Savings Bank, F.S.B., effective July 15, 2026, due to retirement. The company expressed appreciation for his 19 years of service and stated that current management and staff will assume his duties until a successor is named. The resignation was not due to any disagreements with the company.

• · David S. Weiant's resignation is effective July 15, 2026.
• · A search has been initiated for Mr. Weiant's successor.
• · Current management and staff will assume Mr. Weiant's duties until a successor is named.
• · The retirement was not the result of any disagreements with the Corporation or the Bank.

28-05-2026

Beeline Holdings, Inc. (BLNE) disclosed on May 28, 2026 that Board member Eric Finnsson resigned effective June 30, 2026, reducing the Board from six to five directors. The resignation was not due to any disagreement with the company on operations, policies, or practices. With the departure of a director who was part of the legacy Eastside board brought in post-October 2024 merger to aid integration, the transition suggests the company is moving to a leaner governance structure.

• · Eric Finnsson was a member of the Eastside Board of Directors prior to the October 2024 merger.
• · The Company believed it was important to maintain an additional director position to facilitate the integration process.
• · The resignation is effective June 30, 2026, and the filing was made on May 28, 2026.

28-05-2026

Ondas Holdings Inc. filed a Certificate of Amendment with the Nevada Secretary of State to increase its authorized common shares from an unspecified prior amount to 1,200,000,000 shares (par value $0.0001 per share), while authorized preferred shares remain at 10,000,000 shares. The amendment was approved by 87% of votes cast and is effective upon filing. This change may be preparatory for future capital raising activities.

• · The amendment was filed under NRS 78.385 and 78.390 (after issuance of stock).
• · The filing date is May 28, 2026.
• · The entity's Nevada Business Identification Number is E0640082014-2.
• · The amendment deletes and replaces Section 4.1 of Article IV of the Articles of Incorporation.

28-05-2026

EnerSys announced a realignment from four to three operating segments (NIS, IMS, PPS) effective Q1 FY2027, consolidating New Ventures and redistributing corporate charges. The company reaffirmed its unchanged Q1 FY2027 guidance issued on May 20, 2026, and provided recast prior-year segment financials. No financial impact or performance metrics were disclosed, resulting in a neutral sentiment.

• · New Ventures will no longer be a separate operating segment; its sales will be reported within the segments where they occur.
• · Prior costs associated with New Ventures have been allocated as part of corporate charges.
• · Corporate charges are being redistributed across all lines of business based on a new allocation method.
• · The company provided a recast of comparable prior year segment unaudited financial information for fiscal years 2025 and 2026.
• · Consolidated balance sheets, income statements, and statements of cash flows are not affected by the realignment.

28-05-2026

Karyopharm Therapeutics held its 2026 Annual Meeting on May 21, 2026, where stockholders approved an amendment to the 2022 Equity Incentive Plan increasing authorized shares by 3,000,000, elected Barry E. Greene and Christy J. Oliger as Class I directors, and ratified Ernst & Young as auditor. Subsequently, on May 22, 2026, the Compensation Committee approved a broad-based retention program granting performance-based restricted stock units (PSUs) totaling 3,838,380 shares to employees, including named executive officers and the CEO, with vesting tied to clinical milestones and continued service. However, the Second PSU Award also requires stockholder approval of an additional 950,000 share increase by May 31, 2027, introducing conditional risk.

• · Stockholders approved a 1,400,000 share increase to the Employee Stock Purchase Plan.
• · Advisory vote on named executive officer compensation passed with 10,025,198 for vs. 1,388,274 against (87.8% approval).
• · Ratification of Ernst & Young as auditor received 16,695,588 votes for, 86,550 against, and 59,428 abstentions.
• · The Second PSU Award for all participants requires stockholder approval of an additional 950,000 share increase by May 31, 2027.
• · The Retention Program PSUs vest based on clinical milestones, not time-based vesting.

28-05-2026

BorgWarner Inc. appointed Stefan Demmerle as Vice President, President and General Manager of Battery Energy Systems, and Chief Technology Officer, effective July 1, 2026. He previously served as Vice President and President and General Manager of BorgWarner PowerDrive Systems since 2015. No changes were made to his compensatory arrangements.

• · Appointment effective July 1, 2026.
• · Mr. Demmerle had been Vice President and President and General Manager of BorgWarner PowerDrive Systems since 2015.
• · No changes to compensatory arrangements.

28-05-2026

The Hershey Company announced the appointment of Mitchell Arends as Chief Supply Chain Officer, effective June 22, 2026, succeeding Jason Reiman who is retiring after a 30-year career. Reiman will remain through April 2027 to ensure a smooth transition. Arends brings over 25 years of supply chain leadership from UTZ Brands and Kraft Heinz, and will focus on accelerating digital integration and automation.

• · Arends previously served as EVP, Principal Operating Officer, and Chief Integrated Supply Chain Officer at UTZ Brands with full operational accountability for a $1.5B business.
• · Prior to UTZ, Arends was Chief Supply Chain Officer of North America at Kraft Heinz, responsible for a $22B supply chain.
• · Reiman joined Hershey as an intern and built a career spanning the full breadth of the supply chain over 30 years.
• · Reiman's contributions include bringing core capacity and expanded confection capabilities in-house, standing up two fully digitally integrated manufacturing facilities, and building the salty snacks network that is now 80% insourced.
• · Hershey generates more than $11.7 billion in annual revenues with over 20,000 employees worldwide across more than 85 brands in approximately 65 countries.

28-05-2026

At Verizon's 2026 Annual Meeting on May 21, 2026, shareholders approved the 2026 Long-Term Incentive Plan and elected all nine director nominees, with Carol Tomé receiving the highest support (2.73B votes for) and Shellye Archambeau the most opposition (241.5M against). However, two shareholder proposals—on climate change oversight and independent board chair—were both defeated by wide margins, and the executive compensation advisory vote passed with 2.40B for but 355.7M against (12.9% opposition).

• · The shareholder proposal on climate change oversight was defeated with 2.26B votes against vs. 440.8M for.
• · The shareholder proposal for an independent board chair was defeated with 2.31B votes against vs. 434.9M for.
• · Ernst & Young LLP was ratified as independent auditor with 3.16B votes for and 248.0M against.
• · The advisory vote on executive compensation passed with 2.40B for and 355.7M against (12.9% opposition).
• · The shareholder proposal regarding risks of non-fiduciary executive compensation metrics was withdrawn and not presented.

28-05-2026

Ferrellgas Partners, L.P. announced board updates and succession planning developments, including the appointment of Andrew Safran to the Board and Pamela A. Breuckmann as Vice Chair, effective May 21-22, 2026. The company also highlighted recent financial achievements such as the renewal of its Credit Agreement, refinancing of Senior Notes due 2026, and conversion of all outstanding Class B Units into Class A Units, which have improved financial flexibility and simplified the capital structure. No negative or flat financial metrics were disclosed in this filing.

• · Ferrellgas serves propane customers in all 50 states, the District of Columbia, and Puerto Rico.
• · The company filed its Annual Report on Form 10-K for fiscal year ended July 31, 2025, on October 15, 2025.
• · Jim Ferrell has led the company since 1965, transforming it from a small local operation into a Fortune 1000 company.
• · Andrew Safran brings over 30 years of investment banking and private equity experience in natural resources and energy infrastructure.

28-05-2026

CleanCore Solutions, Inc. (ZONE) announced the resignation of David Enholm from the Board of Directors effective May 21, 2026, though he remains CFO. The Board simultaneously appointed CEO Tyler Hassen to fill the vacancy, effective immediately.

• · Mr. Enholm's resignation was not due to any disagreement with the company on operations, policies, or practices.
• · Tyler Hassen, age 43, has served as CEO since March 16, 2026.
• · Mr. Hassen founded Stable Crest Holdings in November 2025 and previously held roles at Basin Holdings and Morgan Stanley.
• · Mr. Hassen holds an undergraduate degree from Princeton University.
• · No arrangements or understandings exist between Mr. Hassen and any other person regarding his director selection.
• · No family relationships exist between Mr. Hassen and any other director or executive officer.
• · No reportable transactions under Item 404(a) of Regulation S-K.

28-05-2026

UGI Corporation announced that Kathleen Shea Ballay, General Counsel and Chief Legal Officer, intends to resign effective July 3, 2026. Her duties will be assumed by internal legal team members until a successor is named. The filing does not provide any financial or operational metrics, so no period-over-period comparisons are available.

• · Resignation effective date: July 3, 2026
• · Successor not yet named; internal legal team will assume duties in the interim

28-05-2026

Cineverse Corp. (CNVS) announced the departure of CFO Mark Lindsey effective May 10, 2026, and entered into a separation letter and consulting agreement. The company will pay Mr. Lindsey his base salary for 12 months in equal monthly installments, while he will continue to vest restricted stock units through the consulting term ending September 13, 2027. No financial performance metrics or period-over-period comparisons are provided in this filing.

• · Separation letter signed May 21, 2026, dated as of May 8, 2026.
• · Consulting agreement signed May 21, 2026, dated as of May 9, 2026.
• · Consulting term ends September 13, 2027.
• · Mr. Lindsey will provide senior financial consulting services in exchange for continued vesting of restricted stock units.

28-05-2026

Intuitive Surgical announced the promotion of Taylor Patton to Chief Commercial and Marketing Officer effective July 1, succeeding Henry Charlton who will become SVP of Global Business Operations. Patton has nearly two decades at Intuitive and led the global launch of the Ion platform. The transition aims to support continued global growth and customer support.

• · Patton has held leadership positions in commercial, marketing, and clinical application engineering.
• · Charlton has been with Intuitive since 2003.
• · Patton will join Intuitive's Executive Leadership team.
• · The transition is effective July 1, 2026.

28-05-2026

Blue Ridge Bankshares, Inc. (BRBS) announced that M. Dean Brown will step down as Chief Operations and Technology Officer, effective June 30, 2026, as part of his retirement. Mr. Brown will also resign from all officer and fiduciary positions at both the Company and its wholly owned subsidiary, Blue Ridge Bank, National Association. No successor or interim replacement has been disclosed in this filing.

• · The separation agreement was reached between the board of directors and Mr. Brown.
• · Mr. Brown's resignation from all officer and fiduciary positions is effective June 30, 2026.
• · The filing does not disclose any compensatory arrangements or severance terms related to the separation.

28-05-2026

Harley-Davidson held its 2026 Annual Meeting on May 21, 2026, where shareholders approved an amendment to the 2020 Incentive Stock Plan to increase authorized shares to 12,200,000, and elected all eight director nominees. The advisory vote on executive compensation (Say-on-Pay) passed with 61,057,442 votes for and 9,796,616 against, while a shareholder proposal on a climate transition plan was overwhelmingly rejected with only 15,168,872 votes for versus 55,305,212 against.

• · The advisory Say-on-Pay vote received 61,057,442 votes for and 9,796,616 against, with 235,983 abstentions and 13,525,983 broker non-votes.
• · The shareholder proposal on a climate transition plan was rejected with 15,168,872 votes for, 55,305,212 against, 615,957 abstentions, and 13,525,983 broker non-votes.
• · The ratification of Ernst & Young as auditor for FY2026 passed with 83,047,856 votes for, 1,378,822 against, and 189,346 abstentions.
• · All eight director nominees were elected, with votes for ranging from 59,736,688 (Allan Golston) to 70,012,530 (Artie Starrs).

28-05-2026

Red River Bancshares, Inc. announced the retirement of long-serving board member Kirk D. Cooper, effective May 7, 2026, and the appointment of A. Peyton Bush, IV and R. Chance DeWitt, M.D. to the boards of the Company and Red River Bank, effective May 28, 2026. Following these changes, the board will have ten directors. The appointments fill vacancies created by Cooper's retirement and a prior resignation.

• · Kirk D. Cooper served on the board since 1998 (Company) and 1999 (Bank).
• · A. Peyton Bush, IV is Chief Investment Officer of Bollinger Enterprises, LLC and has experience at LongueVue Capital, Highland Capital Management, and JP Morgan Securities.
• · R. Chance DeWitt, M.D. is a cardiothoracic and vascular surgeon and serves as director of cardiac rehabilitation and medical director of the Structural Heart Program at Our Lady of Lourdes Heart Hospital.
• · Red River Bank operates 28 banking centers and three combined loan and deposit production offices in Louisiana.

28-05-2026

On May 28, 2026, Marathon Bancorp, Inc. (MBBC) held a Special Meeting of Stockholders where the 2026 Equity Incentive Plan was approved by a vote of 2,024,653 in favor, 135,220 against, and 98,908 abstentions, with no broker non-votes. The plan provides for stock-based awards to officers, employees, and directors of the company and its subsidiary Marathon Bank. No departures or officer changes were reported in this filing.

• · The 2026 Equity Incentive Plan was approved by stockholders at a Special Meeting on May 28, 2026.
• · The plan covers officers, employees, and directors of Marathon Bancorp and its subsidiary Marathon Bank.
• · The proxy statement detailing the plan was filed with the SEC on April 24, 2026.
• · The plan document is filed as Exhibit 10.1 to this 8-K.

28-05-2026

Allogene Therapeutics announced the appointment of Zachary Roberts, M.D., Ph.D. as President and CEO effective July 1, 2026, replacing David Chang, M.D., Ph.D., who will step down from those roles on June 30, 2026 but remain on the Board as a non-employee director. Dr. Roberts, previously EVP of R&D and Chief Medical Officer, will receive an annual base salary of $680,000, a 60% target cash incentive, and equity awards totaling 610,720 shares. Dr. Chang will receive severance benefits under the company's Change in Control and Severance Benefit Plan.

• · David Chang's last day as President and CEO is June 30, 2026
• · Zachary Roberts will continue as interim Chief Medical Officer after the Effective Date
• · Roberts' stock options vest 1/4 after one year, then monthly for 36 months; RSUs vest in four equal annual installments
• · Roberts is entitled to severance and change of control benefits under the Severance Plan
• · Roberts previously held roles at Instil Bio (CMO, Mar 2020-Nov 2022), Kite (VP Clinical Development, Feb 2018-May 2019), and Amgen (Clinical Research Medical Director, Jan 2015-Jul 2015)

28-05-2026

OceanFirst Financial Corp. held its 2026 Annual Meeting on May 27, 2026, where stockholders approved the 2026 Stock Incentive Plan and ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2026. All 13 director nominees were elected, and the advisory vote on executive compensation passed. However, the 2026 Stock Incentive Plan received notable opposition with 2,757,137 votes against and 888,986 abstentions, representing about 8.0% of votes cast against the plan.

• · The advisory vote on executive compensation passed with 42,473,812 votes for, 1,816,614 against, and 1,005,483 abstentions.
• · Ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2026 received 49,515,766 votes for, 205,551 against, and 1,040,969 abstentions.
• · The 2026 Stock Incentive Plan was approved with 41,649,786 votes for, 2,757,137 against, and 888,986 abstentions.
• · All 13 director nominees were elected with votes for ranging from 43,541,230 to 44,642,369.
• · Broker non-votes totaled 5,466,377 on all director elections and matters 1-3, but were not applicable on matter 4 (auditor ratification).

28-05-2026

Microvast Holdings, Inc. reported the departure of Chief Accounting Officer Eric N. Garcia on May 27, 2026. Separately, CEO and Chairman Yang Wu converted the full $25.0 million principal amount of a convertible loan into common stock on May 28, 2026, eliminating a debt liability but potentially diluting existing shareholders.

• · Eric N. Garcia ceased to be employed as Chief Accounting Officer on May 27, 2026.
• · The convertible loan agreement was originally entered into on May 28, 2024, and amended on March 17, 2025 to extend the maturity date to May 28, 2026.
• · The conversion of the $25.0M loan by CEO Yang Wu removes a debt obligation but will increase the number of outstanding common shares.

28-05-2026

Customers Bancorp, Inc. held its Annual Meeting on May 26, 2026, where shareholders approved an amendment to the 2019 Stock Incentive Plan, increasing authorized shares by 750,000 to 4,070,325. The company also disclosed grants of restricted stock units (RSUs) and performance-based RSUs to executives, with aggregate grant date fair values of approximately $2.9 million for short-term awards and $2.8 million for long-term awards. Shareholder votes showed strong support for director elections and auditor ratification, but advisory say-on-pay received 32% against votes, indicating some dissent.

• · The amendment to the 2019 Stock Incentive Plan increased authorized shares from 3,320,325 to 4,070,325.
• · Short-term RSUs granted on March 13, 2026, with closing price $64.72 per share.
• · Long-term RSUs and PBRSUs granted on April 8, 2026, with closing price $73.80 per share.
• · PBRSUs vest based on 3-year relative TSR, ROACE, and NPA ratio metrics with performance multipliers from 50% to 150%.
• · Advisory say-on-pay received 9,059,302 votes against (32% of votes cast), indicating significant shareholder dissent.
• · All three Class III directors were elected with over 26 million votes FOR each.
• · Ratification of Deloitte & Touche LLP passed with 30,414,702 votes FOR (99.5% of votes cast).

28-05-2026

AIxCrypto Holdings, Inc. (AIXC) announced the simultaneous resignation of its Co-CEO Kevin Richardson II, CFO Koti Meka (effective June 20, 2026), and President Campbell Becher on May 21, 2026, with all departures stated as not due to any disagreement with the company. The board appointed Jie (Jay) Sheng as President and CFO (effective June 21, 2026) with an annual base salary of $400,000 and a discretionary bonus of up to $200,000, and appointed Jerry Wang (current Co-CEO and nephew of majority shareholder CEO Yueting Jia) and Chen Shi as directors. Additionally, the board approved the discontinuation and wind-down of the legacy biotechnology business segment, with financial impacts to be evaluated and disclosed in the next periodic report.

• · Kevin Richardson II resigned as Co-CEO and director effective immediately on May 21, 2026.
• · Koti Meka resigned as director effective immediately and as CFO effective June 20, 2026.
• · Campbell Becher resigned as President effective immediately on May 21, 2026.
• · Jie (Jay) Sheng, age 42, served as independent director from October 2, 2025 to May 21, 2026, and chaired the audit committee.
• · Jerry Wang, age 35, is a nephew of Yueting Jia, CEO of the company's majority shareholder.
• · Chen Shi, age 39, is a CFA, FCCA, ACA (ICAEW), and CPA (Canada) with experience at Deloitte and VRB Energy.
• · The board approved the discontinuation and structured wind-down of the legacy biotechnology business segment; financial impact is still being evaluated.
• · No financial figures for the biotechnology segment or any prior-period comparisons were provided in this filing.

28-05-2026

BiomX Inc. appointed Roy Rousso as Chief Business Officer (also designated as Chief Operating Officer and Chief Business Officer under his consulting agreement), effective July 1, 2026. Mr. Rousso, a Colonel (res.) in the IDF with experience at Flexnode and Pente Networks, will receive a monthly fee of $11,900 (pro-rated to a 70% engagement level), eligibility for an annual performance bonus of up to 50% of base fees, and a 200,000-share equity award vesting over three years. The appointment adds executive leadership to support the company's business development activities.

• · Mr. Rousso's appointment is effective July 1, 2026, under a Consulting Agreement dated May 20, 2026.
• · He will serve as both Chief Operating Officer and Chief Business Officer (COO/CBO), with the title potentially modified by mutual agreement.
• · The agreement includes a 12-month non-competition and 12-month non-solicitation covenant.
• · Upon termination without cause or change of control, the equity award vesting schedule shifts to equal monthly installments over three years, with an additional six months of credited service.
• · The parties intend to potentially transition to a full-time employment relationship as the company develops, subject to board approval.
• · Mr. Rousso holds an MBA from Paris School of Business, a master's in Political Science from Bar-Ilan University, and a BA in Political Science from Tel Aviv University.

28-05-2026

CECO Environmental Corp. and Thermon Group Holdings announced that stockholders at both companies overwhelmingly approved their strategic combination, with 99.93% of CECO votes and 99.97% of Thermon votes cast in favor. The transaction is expected to close on or around June 1, 2026. Thermon also disclosed final merger consideration elections, resulting in prorated allocations for Stock Consideration electors.

• · Deadline for Thermon stockholder elections was 5:00 p.m. Central Time on May 22, 2026.
• · Stock Consideration electors: each share converts to approx. $1.48 cash + 0.7920 CECO shares (prorated).
• · Cash Consideration electors: each share converts to $63.89 cash (no proration).
• · Mixed Consideration electors: each share converts to $10.00 cash + 0.6840 CECO shares.
• · Thermon stockholders who did not make a valid election receive Mixed Consideration.
• · Cash will be paid in lieu of fractional CECO shares.
• · Joint proxy statement/prospectus dated April 23, 2026.

28-05-2026

Tyson Foods announced that Jeff Schomburger will succeed Donnie King as President and CEO, effective October 4, 2026, following a transition period beginning in July. Schomburger, a board member since 2016 and Lead Independent Director since 2025, brings extensive consumer brand experience from Procter & Gamble. The company reaffirmed its fiscal 2026 guidance, indicating stable near-term outlook, while King will remain on the board to ensure a smooth transition.

• · Schomburger served as Lead Independent Director since 2025 and chaired the Strategy and Acquisitions Committee since 2021.
• · Donnie King led the company through the COVID-19 pandemic and improved execution to grow profit and strengthen the balance sheet.
• · The company reaffirmed its previously issued total company guidance for fiscal 2026.
• · Tyson Foods was founded in 1935 and is headquartered in Springdale, Arkansas.

28-05-2026

Alto Neuroscience appointed Andrew Miller, Ph.D. to its Board of Directors on May 27, 2026, filling a vacancy created by increasing the board size from six to seven directors. Dr. Miller, founder of Karuna Therapeutics (acquired by Bristol Myers Squibb), will serve as a Class III director until the 2027 Annual Meeting and also join the Nominating and Corporate Governance Committee. The filing does not include any financial results or period-over-period comparisons.

• · Dr. Miller was appointed as a Class III director with a term expiring at the 2027 Annual Meeting of Stockholders.
• · He replaces Christopher Nixon Cox on the Nominating and Corporate Governance Committee.
• · Dr. Miller is deemed independent under NYSE and SEC rules.
• · He received a standard form indemnification agreement from the Company.
• · The board committees post-appointment are listed in the filing.

28-05-2026

California BanCorp declared a regular quarterly cash dividend of $0.10 per share, payable on July 15, 2026, to shareholders of record as of June 23, 2026. This filing primarily covers the dividend announcement and does not include financial results or period-over-period comparisons.

• · Dividend payable on July 15, 2026
• · Record date: June 23, 2026
• · Bank operates 14 branch offices, including 11 commercial banking offices in California
• · Bank established in 2001, headquartered in Del Mar, California

28-05-2026

Vir Biotechnology, Inc. announced the departure of board member and Audit Committee Chair Saira Ramasastry due to a business conflict, effective May 26, 2026, with no disagreement related to company operations. The board appointed Robert More as Audit Committee Chair and reduced board size from eight to seven members. At the 2026 Annual Meeting, stockholders elected three Class I directors (Robert More, Janet Napolitano, Elliott Sigal) and approved executive compensation and the ratification of Ernst & Young as auditor, though Janet Napolitano received a significant 44.7% withhold vote, indicating notable shareholder dissent.

• · Janet Napolitano received 54,454,756 votes withheld (44.7% of votes cast excluding broker non-votes), significantly higher than other directors.
• · Advisory vote on executive compensation had 11,863,405 votes against (9.9% of votes cast excluding broker non-votes) and 1,372,563 abstentions.
• · Ratification of Ernst & Young as auditor passed with 137,048,756 votes for, 153,836 against, and 1,164,682 abstentions.
• · Board size decreased from eight to seven members effective May 26, 2026.

28-05-2026

Western Digital appointed Manuvir Das to its board of directors effective May 26, 2026. Das brings expertise in AI, data infrastructure, and cloud computing from senior roles at NVIDIA, Dell EMC, and Microsoft. The board now comprises nine directors, eight of whom are independent.

• · Das previously served as Head of Enterprise Computing at NVIDIA, leading enterprise AI strategy.
• · He led Dell EMC's unstructured data storage business, overseeing Isilon NAS and ECS Object platforms.
• · Das was an original engineering leader behind Microsoft Azure development.
• · He holds a master's and PhD in Computer Science from University of Wisconsin and a bachelor's from IIT Bombay.
• · Appointment effective May 26, 2026; press release dated May 28, 2026.

28-05-2026

City Holding Company announced the promotion of David L. Bumgarner, age 61, from Executive Vice President and Chief Financial Officer to Senior Executive Vice President and Chief Financial Officer, effective May 27, 2026. The change reflects a title upgrade with no material change in compensation or benefits, which will remain consistent with existing executive practices.

• · Mr. Bumgarner has served as Executive Vice President and CFO since April 2019.
• · The promotion is effective as of the close of business on May 27, 2026.
• · Compensation and benefits will be materially similar to those disclosed in the Definitive Proxy Statement filed March 27, 2026.

28-05-2026

Fulton Financial Corporation held its 2026 Annual Meeting on May 28, 2026. Director George K. Martin retired from the Board after reaching age 72, in line with corporate governance guidelines. All 10 director nominees were elected, and shareholders approved executive compensation (non-binding) and ratified KPMG LLP as independent auditor for fiscal year 2026.

• · Director George K. Martin retired due to age limit (72) per corporate governance guidelines.
• · All 10 director nominees received substantial support; the lowest 'For' votes were for Denise L. Devine (137,102,206) and Curtis J. Myers (137,475,042).
• · Advisory vote on executive compensation passed with 136,017,805 For, 2,704,141 Against, and 958,337 Abstain.
• · Ratification of KPMG LLP as auditor was approved with 150,683,271 For, 2,191,088 Against, and 481,807 Abstain (no broker non-votes).
• · Broker non-votes were 13,675,883 for director elections and the advisory compensation vote.

28-05-2026

Bel Fuse Inc. announced a strategic realignment, naming Kenneth Lai as Senior Vice President of ITDS, effective late Q2 or early Q3 2026, which resulted in his removal from executive officer status. At the 2026 annual meeting on May 26, 2026, shareholders approved all management proposals, including the election of directors Rita V. Smith and Jacqueline Brito, ratification of Deloitte & Touche as auditor, advisory approval of executive compensation, and the 2026 Equity Compensation Plan. However, a shareholder proposal to allow Class A shareholders to convert shares into Class B stock was rejected, with 1,016,457 votes against versus 736,905 in favor.

• · Kenneth Lai's responsibilities expand to include India and private label operations, in addition to China and other Asia locations.
• · The 2026 Plan was approved with 1,571,450 votes for, 13,739 against, and 170,712 abstentions (plus 158,418 broker non-votes).
• · Advisory vote on executive compensation: 1,564,823 for, 20,528 against, 170,550 abstentions.
• · Ratification of Deloitte & Touche: 1,785,986 for, 428 against, 127,905 abstentions.
• · Shareholder proposal to allow Class A to Class B conversion was rejected: 736,905 for, 1,016,457 against, 2,539 abstentions.

28-05-2026

Lennox International Inc. reported the resignation of board member Sivasankaran Somasundaram effective May 23, 2026, due to other professional commitments, with no disagreement with the company; the board was reduced from nine to eight members. At the May 21, 2026 annual meeting, shareholders elected three Class I directors, approved executive compensation with 98% support, and ratified Ernst & Young LLP as auditor for fiscal 2026. The advisory vote on executive compensation received strong approval, while all director nominees faced some votes against, notably Karen H. Quintos with 1,996,509 votes against.

• · Record date for voting: March 26, 2026, with 34,817,885 shares outstanding.
• · Broker non-votes were 2,790,257 for director elections and the executive compensation vote, but zero for auditor ratification.
• · Ratification of Ernst & Young received 32,108,994 votes for, 8,961 against, and 14,681 abstentions.

28-05-2026

Kopin Corporation held its 2026 Annual Meeting on May 21, 2026, where stockholders approved an amendment to the 2020 Equity Incentive Plan to increase share availability and extend the plan term, and elected all five director nominees. The company also ratified BDO USA as its independent auditor and approved, on an advisory basis, the compensation of named executive officers.

• · The annual meeting was held on May 21, 2026; the 8-K was filed on May 28, 2026.
• · All five director nominees were elected with votes for ranging from 69,327,462 to 69,720,247; broker non-votes were 44,251,551 for each.
• · The amended equity plan was approved with 68,660,986 votes for, 849,750 against, and 549,834 abstain.
• · Ratification of BDO USA as auditor received 112,844,182 votes for, 1,223,442 against, and 244,497 abstain (no broker non-votes).
• · The advisory vote on executive compensation passed with 68,891,995 votes for, 879,772 against, and 288,803 abstain.
• · The amendment to the 2020 Equity Incentive Plan increases the number of shares available for issuance and extends the plan term.
• · The Board of Directors had previously approved the amendment on April 16, 2026, subject to stockholder approval.

28-05-2026

On May 28, 2026, Planet Green Holdings Corp. announced the resignation of CFO and board member Lili Hu for personal reasons, effective immediately. The company appointed Wei Li as the new CFO and board member, effective the same day. Ms. Li brings over 10 years of financial management experience, including prior service as CFO of a former subsidiary.

• · Ms. Li, age 34, holds a bachelor's degree in finance from Hubei Technology College (June 2015) and the qualification of Intermediate Accountant in China.
• · Ms. Li's most recent role was audit manager at Wuhan Pingdaochuan CPA from September 2025 to May 2026.
• · Ms. Li served as CFO of Jiayi Technology (Xianning) Co., Ltd., a former subsidiary of the company, from August 2019 to September 2025.
• · Ms. Li's compensation will be consistent with the company's practices for similarly situated executive officers; material terms will be disclosed later.
• · There are no family relationships or arrangements with other persons regarding her appointment, and no transactions requiring disclosure under Item 404(a).

28-05-2026

GSI Technology's Compensation Committee adopted the 2027 Variable Compensation Plan on May 26, 2026, providing cash bonus awards to executive and key employees based on fiscal 2027 performance metrics tied to SRAM and APU net revenue and APU R&D funding. CEO Lee-Lean Shu's target bonus is $275,000, while other executive officers have target bonuses of $137,500 each. However, payouts are subject to extended vesting (60% in April 2027, with 20% in each of the following two years), and actual awards may range from zero to up to two times target, introducing significant performance uncertainty.

• · Plan was adopted by the Compensation Committee of the Board on May 26, 2026.
• · Eligible participants include executive officers, certain non-executive officers, and key employees.
• · Performance criteria include SRAM net revenue, APU net revenue, and/or R&D funding recorded as offset to R&D expense for APU products.
• · If target performance goals are exceeded, actual bonus awards may reach up to two times the target bonus.
• · Vesting schedule: 60% payable on last business day of April 2027; 20% on last business day of April 2028; 20% on last business day of April 2029.
• · Plan is similar in structure to previous variable compensation plans.
• · Filing includes Exhibit 10.1 (the 2027 Plan document) and Exhibit 104 (Cover Page Interactive Data File).

28-05-2026

TFS Financial Corporation (NASDAQ: TFSL) declared a quarterly cash dividend of $0.2825 per share, payable June 24, 2026 to holders of record June 10, 2026. The mutual holding company MHC, which owns 81% of TFSL shares, has waived its right to receive this dividend, continuing a pattern of dividend waivers totaling $0.8475 per share over the prior three quarters. The MHC's waiver authority extends through July 8, 2026 for up to $1.13 per share in aggregate waivers.

• · Dividend payable date: June 24, 2026; record date: June 10, 2026
• · MHC owns 227,119,132 shares, representing 81% of outstanding common stock
• · MHC waiver runs through July 8, 2026; remaining waiver capacity per share is approximately $0.2825 ($1.13 - $0.8475) if the next quarterly dividend is also waived
• · Company assets totaled $17.48 billion as of March 31, 2026
• · MHC received member approval for waiver on July 8, 2025 and non-objection from the Federal Reserve Bank of Cleveland
• · Third Federal operates 21 branches in Northeast Ohio, 2 lending offices in Central/Southern Ohio, and 15 branches in Florida; lends in 28 states and DC

28-05-2026

BrainStorm Cell Therapeutics appointed former FDA Associate Commissioner Peter J. Pitts to its Board of Directors, effective immediately, as the company prepares to initiate its Phase 3b ENDURANCE trial for NurOwn® in ALS under a recently executed Special Protocol Assessment (SPA) – the first SPA ever granted for an ALS therapeutic candidate. The appointment brings significant regulatory expertise, but the company's ability to initiate the trial remains contingent on securing necessary funding, and the filing contains no financial results or operational metrics, highlighting ongoing capital needs and the early-stage nature of the program.

• · Peter J. Pitts previously served as Associate Commissioner at the FDA and as a member of the U.S. Senior Executive Service.
• · The Phase 3b ENDURANCE trial is contingent upon BrainStorm acquiring necessary funding.
• · NurOwn® has received Orphan Drug designation from both the FDA and the European Medicines Agency (EMA).
• · BrainStorm has completed a Phase 2 open-label multicenter trial of MSC-NTF cells in progressive multiple sclerosis (MS), supported by a grant from the National MS Society.
• · The company recently received a Notice of Allowance from the U.S. Patent and Trademark Office for a foundational patent covering its exosome technology.

28-05-2026

Sportsman's Warehouse Holdings, Inc. adopted a Second Amended and Restated 2019 Performance Incentive Plan to attract, motivate, and retain employees, officers, directors, and consultants. The plan authorizes a maximum aggregate share limit of 8,167,492 shares of Common Stock (with a new tranche of 1,928,000 shares plus carryovers from prior plans). The plan includes a minimum vesting requirement of one year for most awards, prohibits repricing of stock options/SARs without shareholder approval, and prohibits awards that vest earlier than one year (except for limited carve-outs up to 5% of shares).

• · The plan prohibits repricing of stock options and stock appreciation rights without prior stockholder approval within the preceding 12 months.
• · Awards that result in the issuance of up to 5% of the shares available under the plan may be granted without the one-year minimum vesting requirement.
• · The plan includes automatic adjustment provisions under Section 7.1 for stock splits, dividends, mergers, and other corporate events.
• · The Administrator has broad discretion to accelerate vesting or modify awards, including in cases of retirement, death, disability, or corporate transactions.
• · The Plan is administered by the Board or a committee of directors, and authority may be delegated to officers where permitted by applicable law.

28-05-2026

Utz Brands, Inc. announced the resignation of EVP, Chief Integrated Supply Chain Officer and principal operating officer Mitchell Arends, effective June 19, 2026, to assume a role at another publicly traded company. CEO Howard Friedman will assume the additional role of principal operating officer, and the Executive Leadership Team will absorb supply chain responsibilities. The company also reaffirmed its fiscal year 2026 financial outlook as previously stated on May 6, 2026, with no changes or updates provided.

• · Mr. Arends' resignation was not due to any disagreement on matters relating to the Company's operations, policies, or practices.
• · The Company reaffirmed its fiscal year 2026 financial outlook as previously stated in its May 6, 2026 press release.
• · The filing includes forward-looking statements subject to risks and uncertainties detailed in the Company's Annual Report on Form 10-K for the year ended December 28, 2025.

28-05-2026

Energy Recovery, Inc. announced the appointment of board member Alex Buehler as Interim President and CEO, effective immediately, following the accelerated retirement of David Moon for personal reasons. The board has engaged an executive search firm to find a permanent CEO. While the leadership transition is orderly with an experienced interim CEO, the sudden departure of the prior CEO introduces near-term management uncertainty.

• · Alex Buehler served as Energy Recovery's CFO from 2011 to 2014 and is a current board member.
• · Buehler will step down from the Compensation and Audit Committees, including his role as Audit Chair.
• · Arve Hanstveit has been appointed as Audit Chair.
• · Buehler holds a B.S. in civil engineering from West Point and an MBA from Wharton.
• · The company operates manufacturing and R&D facilities throughout California with global sales and technical support.

28-05-2026

Clorox announced that Chair and CEO Linda Rendle will step down for health reasons after a successor is appointed, triggering a comprehensive CEO search process led by an independent board committee. Rendle will remain in her role during the search and serve as an advisor post-appointment to ensure a smooth transition. The company highlighted its strengthened digital and operational foundation, portfolio shift to faster-growing health and hygiene categories, and continued focus on restoring profitable growth and market share amid a challenging operating environment.

• · Rendle has been CEO for six years and with Clorox for more than two decades.
• · Rendle and CFO Luc Bellet will participate in a fireside chat at the dbAccess Global Consumer Conference on June 3, 2026, in Paris.
• · The company is headquartered in Oakland, California, and was founded in 1913.
• · The operating environment remains challenging, and the company is focused on strengthening execution, advancing innovation, and delivering superior customer value.